Karen Carroll
Posts by Karen Carroll
Recent USPTO Update Provides Blueprint for PTAB Patent Challenge Process
Since the passing of the America Invents Act (AIA) and the implementation of the inter partes review (IPR) process, IPR has become a popular and important avenue …
Post-Myriad Legal and Policy Considerations for Patenting Genetic Inventions
The U.S. Supreme Court’s 2013 ruling in Association for Molecular Pathology v. Myriad Genetics changed the landscape of what is considered patentable material in the context …
The Evolution of Antibody Patents
As the pharmaceutical industry continues to shift toward biologic-based drugs, including monoclonal antibodies, protecting the underlying technology has been and continues to be a priority for companies. …